Pharma Developpement

Pharma Développement: A company committed to health for over 30 years

Founded in 1991, the PHARMA Développement laboratory has established itself as a key player in the pharmaceutical sector. Since its acquisition in 2008 by Mario GIRON, the company has experienced rapid expansion, marked by several strategic advances that have strengthened its position in the international market.

• 2009: Establishment of corticosteroid packaging facilities and entry into the U.S. market. This milestone marked the beginning of the brand’s international expansion, paving the way for global recognition.
• 2012: Expansion into French-speaking Africa, enabling broader access to care for new patients and strengthening the pharmaceutical supply in regions with high demand.
• 2013: Launch of Ydrovit, an innovative oral rehydration solution. This specialized medical product is designed to replenish lost water and minerals, thereby ensuring effective care for patients suffering from dehydration.
• 2015: Introduction of PHARMA Développement products in Iraq, paving the way for new strategic markets.
• 2016: Expansion into Algeria, strengthening the company’s presence in North Africa and consolidating local distribution.
• 2020: Expansion into Asia with the launch of A313 cosmetics in Thailand, demonstrating the laboratory’s commitment to the field of dermocosmetics.
• 2023: Deployment of a new production line for dry formulations, ensuring ever more efficient manufacturing that complies with health standards.

With an international presence, PHARMA Développement continues to expand its product offerings and innovate to meet the growing needs of patients and healthcare professionals.

Strong Values in the Service of Patients

PHARMA Développement stands out for its unwavering commitment to quality, respect, and responsibility. The company places patients at the heart of its strategy by ensuring products are effective, safe, and compliant with international pharmaceutical standards.

Quality and Rigor

Production follows strict Good Manufacturing Practice (GMP) standards, validated bythe French National Agency for Medicines Safety. Each product is tested, inspected, and subjected to a rigorous process to ensure its efficacy and tolerability.

PHARMA Développement pays particular attention to traceability and the security of manufacturing processes to provide patients with medications and health products that meet the strictest health standards.

Team Spirit and Respect

The laboratory makes it a point of honor to value its employees, fostering a supportive, collaborative, and innovation-friendly work environment. This approach strengthens internal cohesion and ensures production that meets the expectations of patients and healthcare professionals.

Respect for business partners and distribution networks is also one of the company’s fundamental commitments. By emphasizing communication, PHARMA Développement builds trust and transparency with its partners.

Responsibility and Performance

PHARMA Développement does more than just manufacture medications: the company works to raise awareness among healthcare professionals about treatment adherence, a major public health issue.

Continuous improvement of production processes, combined with strict compliance with applicable regulations, enables PHARMA Développement to offer tailored, accessible, and effective therapeutic solutions.

A Diverse and Effective Product Line

PHARMA Développement’s products are designed to improve patients’ quality of life, with a diverse range specifically tailored to various medical conditions.

• Dietary supplements: Provide essential minerals and trace elements to maintain energy and vitality. These solutions support the body’s proper functioning by addressing nutritional deficiencies.
• Dietary products: Designed to reduce sodium chloride intake, ideal for people seeking to manage their nutritional balance. These products contribute to a balanced diet by addressing the specific needs of patients with metabolic disorders.
• Foods for Special Medical Purposes (FSMP): Oral rehydration solutions to compensate for water and mineral losses, essential in cases of dehydration, particularly among vulnerable populations.
• Dermocosmetics and hygiene products: A line designed to care for the skin, treat dermatological conditions, and ensure good daily hygiene. This line combines pharmaceutical expertise and dermatological innovation to offer skincare products that respect the skin’s natural balance.
• Medications: A broad spectrum of therapeutic areas covering the digestive tract and metabolism, dermatological treatments, the genitourinary system, as well as musculoskeletal disorders.

With more than three decades of expertise, PHARMA Développement continues to innovate to offer effective, safe products tailored to patients’ needs. Its commitment to quality, compliance with standards, and public health makes it a leading player in the pharmaceutical industry.

The company continues to expand internationally and is constantly developing new solutions to address public health challenges. With advanced technologies, a strong commitment to scientific rigor, and an approach centered on patient well-being, PHARMA Développement has established itself as a major player in the global pharmaceutical sector.